Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Biosimilars Market Worth USD 25 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Amgen, Biocad, Celltrion - Research and Markets

Research and Markets
Posted on: 06 Oct 16

Research and Markets has announced the addition of the "Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis" report to their offering.

The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020.

With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment. Biosimilars are seen as the key weapon to curbing soaring healthcare costs globally.

The lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to curb healthcare costs globally, increasing nationwide government initiatives, and the strong pipeline for the biosimilar drugs is expected to fuel the biosimilars industry.

This 177 Page report with 74 Figures and 27 Tables is analyzed from 6 viewpoints:

  • 1. Global Biosimilars Market and Forecast - By Product Type
  • 2. Global Biosimilars Market and Forecast - By Applications
  • 3. Global Biosimilars Market and Forecast - By Country Wise
  • 4. Global Biosimilars Company - Profile, Revenue, Approved and Pipeline Biosimilars Analysis
  • 5. Country with Biosimilar Guideline and Published Year
  • 6. Global Biosimilars Market - Driving Factors and Challenges

Companies Mentioned:

  • Amgen Inc.
  • Biocad
  • Biocon
  • Celltrion Inc.
  • Dong-A Socio Group
  • Dr. Reddy's Laboratories
  • Intas Pharmaceuticals Ltd.
  • Merck KGaA
  • Mylan
  • Pfizer Inc.
  • Sandoz International GmbH - A Novartis Company
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd

Report Structure:

1. Executive Summary

2. Global Biosimilars Market and Forecast to 2021

3. Global Biosimilars Market Share and Forecast to 2021

4. Global Biosimilars Market and Forecast - By Product Type

5. Global Biosimilars Market and Forecast - By Applications

6. Global Biosimilars Market and Forecast - By Country Wise

7. Global Biosimilars Company - Profile, Revenue, Approved and Pipeline Biosimilars Analysis

8. Biosimilars Approved in Europe

9. Country with Biosimilar Guideline and Published Year

10. Global Biosimilars Market - Driving Factors

11. Global Biosimilars Market - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/4rjgr6/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20161006005551/en/

Business Wire
www.businesswire.com

Last updated on: 06/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.